Inguinal and Femoral Hernia Procedures with MCC DRG Reimbursement

DRG 350 encompasses operative repairs of inguinal and femoral hernias when a Major Complication or Comorbidity is present, reflecting higher clinical complexity. Accurate identification of this Diagnosis-Related Group affects inpatient prospective payment from Centers for Medicare & Medicaid Services because cases with Major Complication or Comorbidity carry higher reimbursement to account for increased resource use.

DRG 350 Overview

DRG 350 covers inpatient admissions for patients undergoing operative repair of inguinal and femoral hernias with a documented Major Complication or Comorbidity. This Diagnosis-Related Group captures cases with higher clinical complexity and resource needs compared with noncomplicated hernia repairs. It matters for Medicare payment because the presence of a Major Complication or Comorbidity increases the relative weight and prospective payment. Hospitals and coders must accurately document and code comorbid conditions to ensure correct assignment to this Diagnosis-Related Group.

Acute perioperative management studies: randomized or observational trials focused on optimizing intraoperative and immediate postoperative care for patients undergoing inguinal or femoral hernia repair who present with major complications (eg, incarcerated, strangulated bowel, or significant comorbidity). These studies enroll older adults and patients with MCCs admitted emergently to evaluate interventions such as anesthesia strategies, fluid and hemodynamic protocols, timing of surgery, and need for bowel resection. Findings are relevant to surgeons, hospitalists, and payers because they can reduce perioperative morbidity, length of stay, and costlier complications that drive hospital resource use under this DRG.
Comparative effectiveness trials of surgical approach and mesh use in high-risk patients: pragmatic trials or large registry-based cohort studies comparing open versus laparoscopic techniques, biologic versus synthetic mesh, or mesh fixation methods specifically in patients with complex presentations or multiple comorbidities. The patient population includes those with recurrent hernias, contamination, obesity, or cardiovascular/respiratory comorbidities where technique choice may affect complications, reoperation rates, and readmissions. Results inform clinical pathways and reimbursement policies by identifying approaches that improve durability and reduce downstream utilization and complication-related payments for this DRG.
Post-discharge outcomes and care coordination research: prospective cohort studies and quality-improvement trials assessing postoperative recovery trajectories, readmission prevention interventions, and patient-reported outcomes in patients discharged after complicated inguinal or femoral hernia repairs with MCCs. These studies target transitions-of-care interventions (eg, enhanced discharge planning, home health, remote monitoring) in older or medically complex patients to measure functional recovery, wound complications, and 30- to 90-day readmissions. Evidence from this area helps providers and payers design programs that lower preventable readmissions and improve value-based reimbursement metrics tied to this DRG.

Acute perioperative management studies: randomized or observational trials focused on optimizing intraoperative and immediate postoperative care for patients undergoing inguinal or femoral hernia repair who present with major complications (eg, incarcerated, strangulated bowel, or significant comorbidity). These studies enroll older adults and patients with MCCs admitted emergently to evaluate interventions such as anesthesia strategies, fluid and hemodynamic protocols, timing of surgery, and need for bowel resection. Findings are relevant to surgeons, hospitalists, and payers because they can reduce perioperative morbidity, length of stay, and costlier complications that drive hospital resource use under this DRG.
Comparative effectiveness trials of surgical approach and mesh use in high-risk patients: pragmatic trials or large registry-based cohort studies comparing open versus laparoscopic techniques, biologic versus synthetic mesh, or mesh fixation methods specifically in patients with complex presentations or multiple comorbidities. The patient population includes those with recurrent hernias, contamination, obesity, or cardiovascular/respiratory comorbidities where technique choice may affect complications, reoperation rates, and readmissions. Results inform clinical pathways and reimbursement policies by identifying approaches that improve durability and reduce downstream utilization and complication-related payments for this DRG.
Post-discharge outcomes and care coordination research: prospective cohort studies and quality-improvement trials assessing postoperative recovery trajectories, readmission prevention interventions, and patient-reported outcomes in patients discharged after complicated inguinal or femoral hernia repairs with MCCs. These studies target transitions-of-care interventions (eg, enhanced discharge planning, home health, remote monitoring) in older or medically complex patients to measure functional recovery, wound complications, and 30- to 90-day readmissions. Evidence from this area helps providers and payers design programs that lower preventable readmissions and improve value-based reimbursement metrics tied to this DRG.

OpenPayer

Summary & Overview

Inguinal and Femoral Hernia Procedures with MCC: Inpatient Reimbursement Overview

DRG 350 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes